TMO Thermo Fisher Scientific Inc

  1. Stocks
  2. Healthcare
  3. NYSE: TMO

Price (delayed)

$574.3

Market cap

$212.35B

P/E Ratio

30.84

Dividend/share

$1.8

EPS

$18.62

Enterprise value

$250.83B

?
Relative Growth: Rel. Growth: 55
Relative Strength: Rel. Strength: 61
Relative Valuation: Rel. Valuation: 35
Relative Profitability: Rel. Profitability: 67

Thermo Fisher Scientific Inc. is the world leader in serving science, with annual revenue over $40 billion. Our Mission is to enable our customers to make the world healthier, cleaner ...

Highlights
TMO's EPS is up by 8% year-on-year and by 2.2% since the previous quarter
Thermo Fisher Scientific's revenue has increased by 7% YoY and by 2.5% from the previous quarter
Thermo Fisher Scientific's quick ratio has decreased by 24% YoY but it has increased by 6% from the previous quarter
The debt has increased by 21% YoY
The stock's price to earnings (P/E) is 9% more than its last 4 quarters average of 28.2
Sector: Healthcare
Industry: Diagnostics & Research
Website: http://www.thermofisher.com
Peers: BDX WAT BIO ISRG

Key stats

What are the main financial stats of TMO

TMO stock price

How has the Thermo Fisher Scientific stock price performed over time
Intraday
-0.43%
1 week
1.06%
1 month
14.55%
1 year
22.8%
YTD
-0.89%
QTD
14.55%

Financial performance

How have Thermo Fisher Scientific's revenue and profit performed over time
Revenue
$46.34B
Gross profit
$18.91B
Operating income
$8.15B
Net income
$6.97B
Gross margin
40.8%
Net margin
15%
The operating income has grown by 10% YoY and by 3.2% from the previous quarter
Thermo Fisher Scientific's revenue has increased by 7% YoY and by 2.5% from the previous quarter
Thermo Fisher Scientific's net income has increased by 6% YoY
Thermo Fisher Scientific's gross profit has increased by 6% YoY and by 2.6% from the previous quarter

Price vs fundamentals

How does TMO's price correlate with its fundamentals

Growth

What is Thermo Fisher Scientific's growth rate over time

Valuation

What is Thermo Fisher Scientific stock price valuation
TMO P/E details
P/E
30.84
P/B
4.05
P/S
4.6
EV/EBIT
27.77
EV/EBITDA
20.95
EV/Sales
5.41
The stock's price to earnings (P/E) is 9% more than its last 4 quarters average of 28.2
TMO's EPS is up by 8% year-on-year and by 2.2% since the previous quarter
The P/B is 13% above the last 4 quarters average of 3.6 but 10% below the 5-year quarterly average of 4.5
The company's equity rose by 4.3% YoY
The P/S is 10% above the last 4 quarters average of 4.2 but 4.2% below the 5-year quarterly average of 4.8
Thermo Fisher Scientific's revenue has increased by 7% YoY and by 2.5% from the previous quarter

Efficiency

How efficient is Thermo Fisher Scientific business performance
TMO's return on invested capital is down by 5% year-on-year
TMO's ROA is down by 4.5% YoY

Dividends

What is TMO's dividend history
Dividend details
DPS
$1.8
Dividend yield
0.31%
Payout ratio
9.9%
Recent dividends

Special dividends are included in TTM DPS and yield

Financial health

How did Thermo Fisher Scientific financials performed over time
The total assets is 87% greater than the total liabilities
Thermo Fisher Scientific's quick ratio has decreased by 24% YoY but it has increased by 6% from the previous quarter
The current ratio has declined by 20% year-on-year
The debt is 19% lower than the equity
The debt has increased by 21% YoY
Thermo Fisher Scientific's debt to equity has increased by 16% YoY but it has decreased by 2.4% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.